All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Camila Morrone in ...

The University of Houston System's general counsel defended the dual course reviews underway across UH campuses on Thursday, telling the Board of Regents that top administrators chose an approach that ...

Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...

Bottom Line: Why Choose UWorld? After spending time inside the platform, UWorld feels the most dialed in for serious ACT repetition and mistake analysis. It keeps everything centered on practice ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Four months after ...

Kesler CPA Review, the CPA review course founded by Bryan Kesler, CPA in 2022, has released its updated 2026 platform covering all six sections of the CPA exam. I’d like to thank Especially, Bryan ...

The Dell XPS 14 brings the company’s flagship laptop back into competition with speedy Intel Core Series 3 chips and a redesign that’s more practical, yet still premium. In 2022, Dell took a big swing ...

The Food and Drug Administration reversed an earlier decision to not review Moderna's flu vaccine and will evaluate the company's modified application for a potential approval, Moderna said on Feb. 18 ...

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA1.16%increase; green up pointing triangle application to sell a new seasonal flu shot after the vaccine ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

Moderna said Wednesday the Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the original submission and fueling ...

Moderna's shares close up 6% Moderna to conduct post-marketing study in older adults FDA decision expected by August 5 Feb 18 (Reuters) - Moderna said on Wednesday the U.S. Food and Drug ...